Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
MAP2K2 mutation
i
Other names:
MAP2K2, MEK2, PRKMK2, Mitogen-activated protein kinase kinase 2
Associations
(4)
News
Trials
C3 | Sensitive
D | Sensitive
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Immune Checkpoint Inhibitors
Immunotherapy
CD Protein Inhibitors
Threonine-Tyrosine Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
Cancel
Melanoma
Pancreatic Ductal Adenocarcinoma
avelumab + binimetinib
C3
MAP2K2 mutation
|
Pancreatic Ductal Adenocarcinoma
|
avelumab + binimetinib
CTLA4 inhibitor
C3
MAP2K2 mutation
|
Melanoma
|
CTLA4 inhibitor
dabrafenib
D
MAP2K2 mutation
|
Melanoma
|
dabrafenib
trametinib
D
MAP2K2 mutation
|
Melanoma
|
trametinib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
